OSTEOSEN JOINT CAPSULES

Indications

• Vitamin C deficiency
• Scurvy
• Adjunct therapy in iron overload conditions

Dosage

Children: Child 1 month–3 years: 125–250 mg daily in 1–2 divided doses; Child 4–11 years: 250–500 mg daily in 1–2 divided doses; Child 12–17 years: 0.5–1 g daily in 1–2 divided doses.

Adults: 500 mg daily, taken in 1-2 divided doses, depending on the clinical condition and dietary needs.

Mechanism of action

Ascorbic acid functions primarily as a reducing agent, facilitating enzymatic reactions in the body, including the hydroxylation of proline and lysine in collagen synthesis. It also plays a role in the absorption of iron from the gastrointestinal tract and enhances the immune response.

Pharmacodynamics

Ascorbic acid is crucial for the maintenance of connective tissue and is involved in the metabolism of several amino acids. Its antioxidant properties help to mitigate oxidative stress and may play a role in reducing the risk of chronic diseases.

Pharmacokinetics

Ascorbic acid is absorbed in the intestines and is widely distributed throughout the body. The renal clearance of ascorbic acid is dose-dependent, with higher doses leading to increased excretion. The half-life varies but is generally around 15 to 30 minutes in healthy individuals, with tissue saturation levels influencing its retention.

Contra-indications

• Hypercalcaemia
• Hyperoxaluria
• Patients with cardiac dysfunction

Adverse effects

• Abdominal pain
• Headache
• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Weight loss
• Polyuria
• Sweating
• Thirst
• Vertigo

Interactions

• Increases risk of cardiovascular adverse effects with iron chelators
• Increases risk of cardiovascular adverse effects with deferiprone
• Increases risk of cardiovascular adverse effects with desferrioxamine

Precautions

• Use with caution in patients with iron overload
• Monitor for symptoms of overdose

Pregnancy

High doses teratogenic in animals but therapeutic doses unlikely to be harmful.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Ascorbic acid 50 mg tablets
• Ascorbic acid 100 mg tablets
• Ascorbic acid 200 mg tablets
• Ascorbic acid 250 mg tablets
• Ascorbic acid 500 mg capsules

Indications

• Symptomatic relief of mild to moderate osteoarthritis of the knee

Dosage

Children: Refer to the BNF for Children for

Adults: 200–400 mg daily, maximum 6.5 mg/kg per day, or 1250 mg once daily, or 1500 mg once daily dissolved in at least 250 mL of water; review treatment if no benefit after 2–3 months.

Mechanism of action

The mechanism of action of glucosamine in joint health is not entirely clear, but it is believed to involve several pathways. Glucosamine is a precursor for glycosaminoglycans, which are essential for cartilage integrity. It may also reduce inflammation by inhibiting interferon gamma and Nuclear factor kappa B subunit 65 (NF-κB p65), which could improve symptoms of arthritis and joint pain. Upon uptake by living cells, glucosamine reacts with ATP to form glucosamine-6-phosphate, further contributing to glycosaminoglycan synthesis.

Pharmacodynamics

Glucosamine is theorized to provide essential building blocks for the synthesis of glycosaminoglycans, potentially slowing the progression of osteoarthritis and alleviating joint pain. Although some studies have indicated modest improvements in joint pain and function among users, the overall evidence remains inconclusive. Glycosaminoglycans are critical for maintaining cartilage elasticity, strength, and flexibility, which are vital for joint health.

Pharmacokinetics

After oral administration, glucosamine is absorbed in the gastrointestinal tract and transported into the bloodstream, where it is metabolized into various forms, including glucosamine-6-phosphate. The exact pharmacokinetics, such as absorption rate and half-life, remain largely undefined, and much of the data is derived from animal studies. Further research is required to clarify its pharmacokinetic profiles in humans.

Adverse effects

• Constipation
• Diarrhoea
• Fatigue
• Gastrointestinal discomfort
• Headache
• Nausea
• Flushing
• Skin reactions

Interactions

• Glucosamine + warfarin: Severe (increases anticoagulant effect)
• Glucosamine + coumarins: Severe (increases anticoagulant effect)
• Glucosamine + acenocoumarol: Unknown (decreases anticoagulant effect)
• Glucosamine + coumarins: Unknown (decreases anticoagulant effect)

Precautions

• Asthma
• Impaired glucose tolerance
• Predisposition to cardiovascular disease

Pregnancy

Safety during pregnancy has not been established; consult with a healthcare provider.

Breast-feeding

Safety during breastfeeding has not been established; consult with a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Alateris®
• Dolenio®
• Glusartel®

Indications

• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Dyspepsia
• Acid-base balance disorders

Dosage

Children: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Adults: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Mechanism of action

Acids exert their effects primarily by dissociating into protons and anions in solution, thereby lowering the pH of the surrounding environment. This proton donation can influence various physiological processes, including enzyme activity, ion transport, and cellular signaling pathways. For example, hydrochloric acid in the stomach aids in digestion and the absorption of certain nutrients.

Pharmacodynamics

The pharmacodynamic effects of acids are largely dependent on their concentration and the specific type of acid involved. Weak acids may dissociate partially, leading to a less pronounced effect, while strong acids fully dissociate, leading to significant changes in pH and potential tissue irritation. Acids can also interact with various receptors and enzymes, influencing metabolic pathways and physiological responses.

Pharmacokinetics

The pharmacokinetics of acids vary widely depending on their chemical structure. Strong acids, such as hydrochloric acid, do not significantly enter systemic circulation due to their rapid dissociation in aqueous environments. Weak acids may be absorbed through the gastrointestinal tract, where their absorption is influenced by pH, solubility, and the presence of food. Metabolism and excretion pathways also vary, with some acids being metabolized to bicarbonate or other metabolites before excretion, primarily via the kidneys.

Adverse effects

• Gastrointestinal irritation
• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Electrolyte imbalance

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of gastrointestinal bleeding
• Consider potential interactions with other medications that may affect gastrointestinal motility or pH levels

Pregnancy

The safety of various acids during pregnancy may vary; consult specific guidelines for each acid. Generally, use should be limited to essential cases.

Breast-feeding

Caution is advised when using acids during breastfeeding; consult specific guidelines for each acid.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Asthma
• Inflammatory bowel disease
• Chronic inflammatory conditions

Dosage

Children: There is limited information on pediatric dosing for Boswellia. Consult the BNF for Children or a healthcare professional for guidance.

Adults: The recommended dosage for adults typically ranges from 300 mg to 1200 mg per day, divided into multiple doses, but specific dosing depends on the formulation and clinical context. Refer to product-specific guidelines for further details.

Mechanism of action

Boswellic acids inhibit the synthesis of leukotrienes, which are inflammatory mediators. The inhibition of 5-lipoxygenase, an enzyme involved in the production of leukotrienes, helps reduce inflammation and modulate immune responses. This mechanism underlies Boswellia's potential benefits in treating inflammatory conditions.

Pharmacodynamics

Boswellia exhibits anti-inflammatory, analgesic, and possibly anti-cancer properties due to its ability to modulate immune mechanisms and inhibit pro-inflammatory pathways. It has been shown to reduce pain and improve functionality in osteoarthritis and rheumatoid arthritis patients.

Pharmacokinetics

After oral administration, Boswellia is absorbed in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours. Its bioavailability is influenced by the formulation and presence of other substances. Boswellic acids are metabolized in the liver, and their elimination half-life is variable. They are primarily excreted in urine and feces.

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Allergic skin reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with NSAIDs due to anti-inflammatory properties

Precautions

• Use with caution in patients with gastrointestinal disorders
• Consider potential effects on blood clotting

Pregnancy

Boswellia should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited data are available.

Breast-feeding

Boswellia is not well-studied in breastfeeding women; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsules
• Tablets
• Resins
• Powder

Indications

• Vitamin D deficiency
• Rickets
• Osteomalacia
• Osteoporosis
• Hypoparathyroidism

Dosage

Adults: The usual adult dose for vitamin D deficiency is 800 to 2000 IU daily, depending on the severity of deficiency and clinical condition. Higher doses may be used under medical supervision.

Mechanism of action

Cholecalciferol is converted to its active forms, 25-hydroxyvitamin D in the liver and 1,25-dihydroxyvitamin D in the kidneys. These metabolites enhance the intestinal absorption of calcium and phosphorus, increase serum calcium levels, and mobilize these minerals from bone. This process is regulated by parathyroid hormone, which influences calcium and phosphate metabolism, particularly in the kidneys.

Pharmacodynamics

The pharmacodynamics of cholecalciferol involve its conversion to active metabolites that play a significant role in calcium and phosphorus homeostasis. The metabolites facilitate intestinal absorption of these minerals, promote bone mineralization, and influence renal reabsorption. The onset of action occurs within 10 to 24 hours following administration, as metabolic activation is required for its biological effects.

Pharmacokinetics

Cholecalciferol is absorbed in the gastrointestinal tract, and its absorption is enhanced by the presence of dietary fats. It is transported in the bloodstream bound to vitamin D-binding protein. Once in the liver, it undergoes hydroxylation to form 25-hydroxyvitamin D, which is further converted in the kidneys to the active form, 1,25-dihydroxyvitamin D. The elimination half-life of cholecalciferol varies, typically spanning several days, and it is primarily excreted in bile and urine.

Adverse effects

• Hypercalcemia
• Hypercalciuria
• Nausea
• Vomiting
• Constipation
• Weakness
• Fatigue

Interactions

• May enhance the effects of thiazide diuretics, leading to increased risk of hypercalcemia
• Anticonvulsants may increase metabolism of vitamin D, leading to reduced effectiveness
• Cholestyramine may reduce absorption of vitamin D

Precautions

• Monitor serum calcium levels in patients with renal impairment
• Caution in patients with a history of hypercalcemia or hyperparathyroidism
• Use with caution in patients taking other medications that affect calcium metabolism

Pregnancy

Cholecalciferol can be used during pregnancy if indicated, as vitamin D is essential for fetal bone development.

Breast-feeding

Cholecalciferol is excreted in breast milk, but is generally considered safe during breastfeeding.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Capsules
• Tablets
• Liquid formulations

Indications

• Osteoarthritis
• Joint pain
• Cartilage repair
• Joint health maintenance

Dosage

Children: Refer to healthcare professionals for guidance on dosing in children, as specific pediatric dosing information is not well established.

Adults: Refer to specific product labeling and consult healthcare professionals for guidance on dosing, as dosages can vary based on formulations and clinical guidelines.

Mechanism of action

Chondroitin works primarily by providing the building blocks necessary for the synthesis of glycosaminoglycans, which are critical components of cartilage. It is thought to inhibit the enzymes that break down cartilage, thereby promoting cartilage repair while also exhibiting anti-inflammatory properties. Additionally, chondroitin may enhance the retention of water in the cartilage, improving its elasticity and resilience.

Pharmacodynamics

Chondroitin has been shown to modulate inflammatory responses within the joints and may help to improve joint mobility and reduce pain associated with osteoarthritis. Its effects on cartilage metabolism are believed to contribute to its therapeutic benefits, although the clinical efficacy may vary among individuals. The anti-inflammatory properties may also contribute to a reduction in joint swelling and discomfort.

Pharmacokinetics

Chondroitin is poorly absorbed from the gastrointestinal tract, with bioavailability ranging from 12% to 36%. It is distributed in the extracellular matrix of cartilage and other connective tissues. Metabolism of chondroitin is not well understood, but it is believed to be metabolized in the liver. The elimination half-life in humans is not well defined, and it is primarily excreted via urine as metabolites. The effects of food on its absorption are still under investigation.

Adverse effects

• Nausea
• Diarrhea
• Constipation
• Abdominal pain
• Headache
• Skin reactions

Interactions

• Anticoagulants (e.g., warfarin) - may increase the risk of bleeding
• NSAIDs - may affect the efficacy of these medications

Precautions

• Use with caution in patients with a history of bleeding disorders
• Caution is advised in patients undergoing surgery due to potential bleeding risk
• Patients with shellfish allergies should consult a physician as some chondroitin supplements are derived from marine sources

Pregnancy

There is insufficient reliable information regarding the safety of chondroitin during pregnancy. It is advisable to avoid use unless prescribed by a healthcare professional.

Breast-feeding

It is not known if chondroitin is excreted in human milk. Caution is advised for nursing mothers considering its use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsule
• Tablet
• Powder
• Liquid

Indications

• Skin aging and wrinkle reduction
• Joint pain and osteoarthritis
• Tendon and ligament injuries
• Bone health
• Wound healing

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing based on the indication and formulation used.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing based on the indication and formulation used.

Mechanism of action

Collagen exerts its effects primarily by providing the necessary amino acids, such as glycine, proline, and hydroxyproline, that are crucial for the synthesis of new collagen in the body. It is thought to stimulate fibroblast proliferation, which leads to increased collagen production and improved tissue repair. Additionally, collagen may enhance the hydration of the skin and improve its elasticity.

Pharmacodynamics

Collagen supplementation may promote the synthesis of new collagen and improve the integrity of the extracellular matrix. This can lead to improved skin hydration, elasticity, and the reduction of wrinkles. In joint health, collagen may help reduce inflammation and pain, contributing to improved mobility and function. The effects can vary based on the source of collagen (bovine, porcine, marine) and the form of administration (powder, liquid, capsules).

Pharmacokinetics

After oral administration, collagen peptides are absorbed in the gastrointestinal tract and enter the bloodstream. They can be transported to various tissues where they may be incorporated into the extracellular matrix. The half-life of collagen peptides is relatively short, and they are metabolized in the liver and other tissues. The bioavailability of collagen can vary based on the formulation and the presence of other dietary components.

Adverse effects

• Allergic reactions
• Skin rash
• Itching
• Gastrointestinal disturbances
• Nausea

Precautions

• Use with caution in individuals with fish allergies if derived from fish sources
• Monitor for allergic reactions

Pregnancy

Collagen is generally considered safe during pregnancy, but consult a healthcare professional before use.

Breast-feeding

Collagen is likely safe during breastfeeding, but consult a healthcare professional before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Liquid

Indications

• Anti-inflammatory therapy
• Antioxidant support
• Adjunctive treatment in cancer
• Cholagogic agent
• Supportive treatment for metabolic syndrome

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in pediatric populations.

Adults: Refer to the BNF for specific dosing guidelines as doses may vary based on formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals, superoxide anions, and singlet oxygen, which leads to the inhibition of lipid peroxidation and protection against peroxide-induced DNA damage. It exerts anti-inflammatory effects by modulating key signaling molecules involved in inflammation, notably inhibiting protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 expression and activity. This multifaceted mechanism contributes to its anti-carcinogenic properties and therapeutic activity against various diseases.

Pharmacodynamics

In animal studies, curcumin has demonstrated significant effects, such as increasing bile flow and inhibiting edema formation in models of inflammation. It has also shown to decrease cell proliferation in cancerous tissues, increase apoptosis, and enhance micro-vessel density in tumor models. Furthermore, curcumin may enhance biliary excretion and inhibit platelet aggregation in vitro, indicating its potential role in cardiovascular health.

Pharmacokinetics

Curcumin undergoes extensive metabolism and has low bioavailability due to poor absorption. It is rapidly conjugated and excreted, primarily in the form of glucuronides and sulfates. The pharmacokinetic profile can be influenced by factors such as formulation, dosage, and the presence of other compounds that enhance its absorption.

Pregnancy

Curcumin should be used with caution during pregnancy. Limited data is available on its safety, and it is advisable to consult healthcare providers before use.

Breast-feeding

Curcumin is excreted in breast milk, and caution is advised when used during breastfeeding. Consultation with healthcare providers is recommended.

Storage

Store in a cool, dry place away from light. Ensure the container is tightly closed.

Formulations

• Curcumin capsules
• Curcumin powder
• Curcumin tinctures
• Curcumin topical formulations

Indications

• General wellness support
• Anti-inflammatory effects
• Antioxidant activity
• Digestive aid
• Support for immune function

Dosage

Children: Paediatric dosing should be determined based on the specific extract and its intended use. Consultation with a healthcare provider is recommended for accurate dosing.

Adults: Dosage varies widely depending on the specific extract and formulation. It is essential to follow the manufacturer's instructions or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of herbal extracts can vary significantly based on their constituents. Commonly, they exert their effects through multiple pathways including modulation of neurotransmitter systems, interference with inflammatory processes, or direct antioxidant activity. Some extracts may activate certain receptors or inhibit enzymes related to disease processes.

Pharmacodynamics

The pharmacodynamics of extracts is complex due to the presence of multiple active compounds which can have synergistic or antagonistic effects. These compounds may influence cellular signaling pathways, alter gene expression, or modulate immune response. The overall pharmacological profile is determined by the specific composition of the extract, its concentration, and the biological target it interacts with.

Pharmacokinetics

The pharmacokinetics of extracts involves absorption, distribution, metabolism, and excretion of the active compounds. Generally, herbal extracts are absorbed in the gastrointestinal tract, with bioavailability influenced by factors such as formulation, the presence of food, and individual metabolic differences. Compounds may undergo hepatic metabolism, and elimination can occur through urine or feces, depending on their chemical nature.

Pregnancy

Consult a healthcare professional before use, as the safety of the extract during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as the safety of the extract during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nutritional support
• Management of dyslipidemia
• Support for cardiovascular health
• Anti-inflammatory therapies

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and condition.

Adults: Dosage varies widely depending on the specific type of fatty acid and the condition being treated. Refer to specific guidelines for dietary or therapeutic doses.

Mechanism of action

Fatty acids exert their effects through several mechanisms, including serving as energy sources, components of cell membrane phospholipids, and precursors for signaling molecules such as eicosanoids. They can modulate gene expression and influence metabolic pathways by activating nuclear receptors, such as peroxisome proliferator-activated receptors (PPARs).

Pharmacodynamics

Fatty acids influence lipid metabolism, inflammation, and insulin sensitivity. They can alter membrane fluidity and receptor function, impacting cellular signaling. Saturated fatty acids may promote inflammatory processes, while unsaturated fatty acids, particularly omega-3 and omega-6 fatty acids, can exert anti-inflammatory effects and promote cardiovascular health.

Pharmacokinetics

Fatty acids are absorbed in the intestine via passive diffusion and are transported in the blood bound to albumin or as part of lipoproteins. They are metabolized in the liver, where they can undergo beta-oxidation to generate energy or be converted into ketone bodies. The half-life varies depending on the type of fatty acid and its incorporation into various tissues.

Pregnancy

Consult with a healthcare provider before use, as the effects of fatty acids during pregnancy can vary.

Breast-feeding

Consult with a healthcare provider before use, as some fatty acids may be excreted in breast milk.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Hormone replacement therapy
• Diabetes management
• Muscle growth enhancement
• Weight loss
• Treatment of certain cancers
• Antimicrobial activity

Dosage

Children: Refer to specific peptide formulations for dosing recommendations, as they vary widely based on the intended use and formulation.

Adults: Refer to specific peptide formulations for dosing recommendations, as they vary widely based on the intended use and formulation.

Mechanism of action

Peptides exert their effects by binding to specific receptors on target cells, initiating a cascade of intracellular signaling pathways. This can lead to various physiological responses such as modulation of enzyme activity, gene expression, and cellular metabolism. The specific mechanism varies according to the peptide's structure and the biological system it affects.

Pharmacodynamics

The pharmacodynamic profile of peptides is closely related to their structure and the receptors they target. Many peptides function as hormones, neurotransmitters, or growth factors, leading to dose-dependent effects. The potency and efficacy of a peptide are influenced by factors such as receptor affinity, downstream signaling pathways, and the presence of receptor antagonists.

Pharmacokinetics

Peptides are typically administered via injection as they can be degraded by gastrointestinal enzymes when taken orally. Their absorption, distribution, metabolism, and elimination vary based on the peptide's size, structure, and formulation. Generally, peptides have short half-lives due to rapid enzymatic degradation. Modifications to peptide structure can enhance stability and bioavailability.

Pregnancy

Safety during pregnancy has not been established; use with caution and only if clearly needed.

Breast-feeding

Safety during breastfeeding has not been established; use with caution.

Storage

Store in a cool, dry place, protected from light and moisture.

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Joint pain
• Inflammation
• Vitamin C deficiency
• Antioxidant support

Dosage

Children: There is no specific paediatric dosage established; refer to product-specific guidelines or consult a healthcare professional for appropriate dosing.

Adults: There is no specific adult dosage established; refer to product-specific guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The exact mechanism of action of rosehips is not fully understood. However, they are believed to exert anti-inflammatory effects primarily due to their high content of vitamin C, flavonoids, and other antioxidants. These compounds may inhibit the production of pro-inflammatory cytokines and reduce oxidative stress, contributing to their therapeutic effects.

Pharmacodynamics

Rosehips have been observed to have anti-inflammatory, antioxidant, and immune-boosting properties. The vitamin C content supports collagen synthesis and may contribute to the maintenance of healthy connective tissues. Additionally, the phenolic compounds present in rosehips may modulate inflammatory pathways, providing potential benefits in conditions such as osteoarthritis and rheumatoid arthritis.

Pharmacokinetics

The pharmacokinetics of rosehips are not well-studied, but the bioavailability of vitamin C and other soluble compounds is generally high when ingested. Absorption occurs in the gastrointestinal tract, with peak plasma concentrations typically reached within a few hours. The metabolites are likely excreted primarily through the kidneys. The pharmacokinetics of rosehip extracts can vary depending on the formulation and preparation method.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Nausea
• Allergic reactions

Precautions

• Use with caution in individuals with a history of allergies to rose family plants
• Consult a healthcare provider before use in patients with chronic medical conditions or those taking other medications

Pregnancy

Limited information is available on the safety of rosehips during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Limited information is available on the safety of rosehips during breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Dried fruit
• Powder
• Capsules
• Teas
• Extracts

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Joint pain
• Inflammatory bowel disease
• Chronic respiratory conditions

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on specific conditions.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on specific conditions.

Mechanism of action

Boswellia serrata contains boswellic acids, which inhibit the 5-lipoxygenase enzyme, leading to a reduction in the synthesis of leukotrienes. This action decreases inflammation and pain associated with various conditions, particularly those affecting the joints. Boswellic acids may also modulate the immune response and possess analgesic properties.

Pharmacodynamics

The pharmacodynamic effects of Boswellia serrata are primarily attributed to its anti-inflammatory and analgesic properties. By inhibiting leukotriene synthesis, it reduces the inflammatory response in the body. Additionally, Boswellia serrata may enhance circulation and improve joint mobility while reducing stiffness and swelling in affected areas.

Pharmacokinetics

Boswellia serrata is absorbed in the gastrointestinal tract, though the bioavailability may vary based on formulation and presence of other compounds. The active boswellic acids are metabolized in the liver, and excretion primarily occurs via the kidneys. The half-life of boswellic acids can vary, but they generally remain in the system long enough to exert their therapeutic effects.

Pregnancy

There is insufficient reliable information regarding the safety of serrata during pregnancy. It is advisable to avoid use unless specifically directed by a healthcare professional.

Breast-feeding

There is limited data on the excretion of serrata components in human milk. Caution is advised, and it is best to consult with a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Prevention of vitamin E deficiency
• Antioxidant therapy
• Support in conditions related to oxidative stress

Dosage

Children: Refer to BNF for Children for specific dosage guidelines.

Adults: Refer to BNF for specific dosage guidelines.

Mechanism of action

Tocopherol acts as a radical scavenger, primarily functioning as an antioxidant for lipid bilayers. It donates hydrogen atoms to free radicals, trapping them and preventing cellular damage. Its effectiveness is influenced by its location within the membrane and its interaction with cytosolic reductants like ascorbate. Tocopherol can trap multiple radicals, including alkyl and peroxy radicals.

Pharmacodynamics

The antioxidant properties of tocopherol lead to significant pharmacodynamic effects, including the inhibition of cell death through modulation of protein kinase C (PKC). Tocopherol also exhibits anti-inflammatory effects, which can be attributed to its influence on cytokines, prostaglandins, prostanoids, and thromboxanes. These interactions may contribute to its protective effects in various pathological conditions.

Pharmacokinetics

Tocopherol is absorbed in the intestines and its bioavailability can be influenced by dietary fat intake. It is transported in the plasma primarily bound to lipoproteins. Tocopherol is stored in adipose tissue and the liver, and its elimination occurs through bile and urine. The half-life of tocopherol can vary depending on the individual's nutritional status and other factors.

Pregnancy

Tocopherol is generally considered safe during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Tocopherol is excreted in breast milk, and while it is considered safe, a healthcare provider should be consulted for specific recommendations.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

The mechanism of action of glucosamine in joint health is unclear, however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis. Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma and Nuclear factor kappa B subunit 65 (NF-κB p65), improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time. When taken up by living cells, glucosamine reacts with ATP to form glucosamine-6-phosphate, the natural precursor of glycosaminoglycans (GAGs) that contain N-acetylglucosamine (keratan sulfate and Hyaluronan) and those that have N-acetylgalactosamine (heparan sulfate and chondroitin sulfate). These GAGs are polysaccharides composed of hexosamines and monosaccharides (e.g., galactose and glucuronic acid) arranged as a linear chain of repeating disaccharide units (such as the glucuronic acid and N-acetylgalactosamine-6-sulfate of chondroitin sulfate). With the exception of hyaluronan, GAGs do not exist alone in nature but are attached to specific "core" proteins, and the composite structures are called proteoglycans (protein-glycosaminoglycans). Both hyaluronan and many different kinds of proteoglycans (such as aggrecan, versican, and syndecan) are abundant throughout the body where they perform diverse functions.

Pharmacodynamics

The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility. A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.

Mechanism of action

Most individuals naturally generate adequate amounts of vitamin D through ordinary dietary intake of vitamin D (in some foods like eggs, fish, and cheese) and natural photochemical conversion of the vitamin D3 precursor 7-dehydrocholesterol in the skin via exposure to sunlight. Conversely, vitamin D deficiency can often occur from a combination of insufficient exposure to sunlight, inadequate dietary intake of vitamin D, genetic defects with endogenous vitamin D receptor, or even severe liver or kidney disease. Such deficiency is known for resulting in conditions like rickets or osteomalacia, all of which reflect inadequate mineralization of bone, enhanced compensatory skeletal demineralization, resultant decreased calcium ion blood concentrations, and increases in the production and secretion of parathyroid hormone. Increases in parathyroid hormone stimulate the mobilization of skeletal calcium and the renal excretion of phosphorus. This enhanced mobilization of skeletal calcium leads towards porotic bone conditions. Ordinarily, while vitamin D3 is made naturally via photochemical processes in the skin, both itself and vitamin D2 can be found in various food and pharmaceutical sources as dietary supplements. The principal biological function of vitamin D is the maintenance of normal levels of serum calcium and phosphorus in the bloodstream by enhancing the efficacy of the small intestine to absorb these minerals from the diet. At the liver, vitamin D3 or D2 is hydroxylated to 25-hydroxyvitamin D and then finally to the primary active metabolite 1,25-dihydroxyvitamin D in the kidney via further hydroxylation. This final metabolite binds to endogenous vitamin d receptors, which results in a variety of regulatory roles - including maintaining calcium balance, the regulation of parathyroid hormone, the promotion of the renal reabsorption of calcium, increased intestinal absorption of calcium and phosphorus, and increased calcium and phosphorus mobilization of calcium and phosphorus from bone to plasma to maintain balanced levels of each in bone and the plasma. In particular, calcitriol interacts with vitamin D receptors in the small intestine to enhance the efficiency of intestinal calcium and phosphorous absorption from about 10-15% to 30-40% and 60% increased to 80%, respectively. Furthermore, calcitriol binds with vitamin D receptors in osteoblasts to stimulate a receptor activator of nuclear factor kB ligand (or RANKL) which subsequently interacts with receptor activator of nuclear factor kB (NFkB) on immature preosteoclasts, causing them to become mature bone-resorbing osteoclasts. Such mature osteoclasts ultimately function in removing calcium and phosphorus from bone to maintain blood calcium and phosphorus levels. Moreover, calcitriol also stimulates calcium reabsorption from the glomerular filtrate in the kidneys. Additionally, it is believed that when calcitriol binds with nuclear vitamin D receptors, that this bound complex itself binds to retinoic acid X receptor (RXR) to generate a heterodimeric complex that consequently binds to specific nucleotide sequences in the DNA called vitamin D response elements. When bound, various transcription factors attach to this complex, resulting in either up or down-regulation of the associated gene's activity. It is thought that there may be as much as 200 to 2000 genes that possess vitamin D response elements or that are influenced indirectly to control a multitude of genes across the genome. It is in this way that cholecalciferol is believed to function in regulating gene transcription associated with cancer risk, autoimmune disorders, and cardiovascular disease linked to vitamin D deficiency. In fact, there has been some research to suggest calcitriol may also be able to prevent malignancies by inducing cellular maturation and inducing apoptosis and inhibiting angiogenesis, exhibit anti-inflammatory effects by inhibiting foam cell formation and promoting angiogenesis in en

Pharmacodynamics

The in vivo synthesis of the predominant two biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of vitamin D3 cholecalciferol (or D2) occurs in the liver to yield 25-hydroxyvitamin D while the second hydroxylation happens in the kidneys to give 1, 25-dihydroxyvitamin D. These vitamin D metabolites subsequently facilitate the active absorption of calcium and phosphorus in the small intestine, serving to increase serum calcium and phosphate levels sufficiently to allow bone mineralization. Conversely, these vitamin D metabolites also assist in mobilizing calcium and phosphate from bone and likely increase the reabsorption of calcium and perhaps also of phosphate via the renal tubules. There exists a period of 10 to 24 hours between the administration of cholecalciferol and the initiation of its action in the body due to the necessity of synthesis of the active vitamin D metabolites in the liver and kidneys. It is parathyroid hormone that is responsible for the regulation of such metabolism at the level of the kidneys.

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.

Mechanism of action

Tocopherol acts as a radical scavenger. It mainly acts as an antioxidant for lipid bilayers. Tocopherol's functions depend on the H-atom donating ability, location, and movement within the membrane, as well as the efficiency in the radical recycling by some cytosolic reductants such as ascorbate. Tocopherol actions are related to the trap of radicals, and it has been shown that even in the absence of substituents in the ortho-positions, tocopherol can trap more than two radicals. The type of radicals available for tocopherol are alkyl and peroxy.

Pharmacodynamics

The antioxidant effects of tocopherol can be translated into different changes at the pharmacodynamic level. In vitro studies have shown that this antioxidant activity can produce modification in protein kinase C (PKC) which will later be translated into an inhibition of cell death. Some other derivate effects are the anti-inflammatory properties of tocopherol which can be related to the modulation of cytokines or prostaglandins, prostanoids and thromboxanes.